Sphere Fluidics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 51

Employees

  • Latest Deal Type
  • M&A

Sphere Fluidics General Information

Description

Operator of a life sciences company intended to develop novel technologies for single-cell analysis, therapy development, and characterization. The company's cell analysis systems assist in the discovery of new cell strains and molecules and help scientists screen for and isolate rare and valuable biological variants across research, therapeutic, bioproduction, and diagnostic applications, enabling clients to reduce cost, and time and accelerate biological and biopharmaceutical discovery.

Contact Information

Formerly Known As
Friars 2013
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Building One, Granta Centre
  • Granta Park, Great Abington
  • Cambridge CB21 6AL
  • England, United Kingdom
+44 01223
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • Building One, Granta Centre
  • Granta Park, Great Abington
  • Cambridge CB21 6AL
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sphere Fluidics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
20. Merger/Acquisition 02-Sep-2025 Completed Generating Revenue
19. PE Growth/Expansion Cancelled Generating Revenue
18. Later Stage VC Completed Generating Revenue
17. Later Stage VC 28-Oct-2021 Completed Generating Revenue
16. Secondary Transaction - Private 01-May-2021 Completed Generating Revenue
15. Debt - General 30-Apr-2020 Completed Generating Revenue
14. Later Stage VC 10-Jun-2019 Completed Generating Revenue
13. Debt - General Completed Generating Revenue
12. Grant 27-Nov-2017 $2.11M $18.9M Completed Generating Revenue
11. Grant 17-Jul-2017 $1.25M $18.9M Completed Generating Revenue
To view Sphere Fluidics’s complete valuation and funding history, request access »

Sphere Fluidics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Series A Preferred
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 2,303 $0.013657 $156.93 $156.93 1x $156.93 1.67%
Ordinary 4,062 $0.013657 $109.25 $109.25 1x $109.25 2.95%
To view Sphere Fluidics’s complete cap table history, request access »

Sphere Fluidics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a life sciences company intended to develop novel technologies for single-cell analysis, therapy development
Discovery Tools (Healthcare)
Cambridge, United Kingdom
51 As of 2025

Cambridge, United Kingdom
 

Munich, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sphere Fluidics Competitors (31)

One of Sphere Fluidics’s 31 competitors is Abcam, a Corporate Backed or Acquired company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abcam Corporate Backed or Acquired Cambridge, United Kingdom
Nanion Technologies Accelerator/Incubator Backed Munich, Germany
HiFiBiO Therapeutics Venture Capital-Backed Cambridge, MA
Genomic Vision Formerly VC-backed Bagneux, France
GnuBIO Formerly VC-backed Cambridge, MA
You’re viewing 5 of 31 competitors. Get the full list »

Sphere Fluidics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sphere Fluidics Former Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
24Haymarket Venture Capital Minority
Amadeus Capital Partners Venture Capital Minority
Angels 5K ( Specialized Finance) Angel Group Minority
Cambridge Angels Angel Group Minority
Cambridge Enterprise Ventures Venture Capital Minority
You’re viewing 5 of 23 investors. Get the full list »

Sphere Fluidics FAQs

  • When was Sphere Fluidics founded?

    Sphere Fluidics was founded in 2010.

  • Where is Sphere Fluidics headquartered?

    Sphere Fluidics is headquartered in Cambridge, United Kingdom.

  • What is the size of Sphere Fluidics?

    Sphere Fluidics has 51 total employees.

  • What industry is Sphere Fluidics in?

    Sphere Fluidics’s primary industry is Discovery Tools (Healthcare).

  • Is Sphere Fluidics a private or public company?

    Sphere Fluidics is a Private company.

  • What is Sphere Fluidics’s current revenue?

    The current revenue for Sphere Fluidics is .

  • How much funding has Sphere Fluidics raised over time?

    Sphere Fluidics has raised $67.1M.

  • Who are Sphere Fluidics’s investors?

    24Haymarket, Amadeus Capital Partners, Angels 5K ( Specialized Finance), Cambridge Angels, and Cambridge Enterprise Ventures are 5 of 23 investors who have invested in Sphere Fluidics.

  • Who are Sphere Fluidics’s competitors?

    Abcam, Nanion Technologies, HiFiBiO Therapeutics, Genomic Vision, and GnuBIO are some of the 31 competitors of Sphere Fluidics.

  • When was Sphere Fluidics acquired?

    Sphere Fluidics was acquired on 02-Sep-2025.

  • Who acquired Sphere Fluidics?

    Sphere Fluidics was acquired by Fluidic Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process